Guardian Pharmacy Services (NYSE:GRDN - Free Report) had its target price hoisted by Truist Financial from $24.00 to $25.00 in a research report report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock.
Guardian Pharmacy Services Trading Up 1.7 %
NYSE GRDN traded up $0.39 during trading hours on Friday, hitting $23.28. 88,138 shares of the company were exchanged, compared to its average volume of 83,820. Guardian Pharmacy Services has a 52 week low of $14.16 and a 52 week high of $25.74. The stock has a 50-day moving average price of $20.43 and a 200 day moving average price of $20.66.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the company. Envestnet Asset Management Inc. boosted its stake in shares of Guardian Pharmacy Services by 4.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company's stock worth $243,000 after purchasing an additional 564 shares during the period. LPL Financial LLC grew its stake in shares of Guardian Pharmacy Services by 4.8% during the fourth quarter. LPL Financial LLC now owns 17,679 shares of the company's stock valued at $358,000 after buying an additional 807 shares during the last quarter. GAMMA Investing LLC purchased a new stake in shares of Guardian Pharmacy Services in the first quarter worth approximately $170,000. Lazard Asset Management LLC lifted its stake in shares of Guardian Pharmacy Services by 0.5% during the 4th quarter. Lazard Asset Management LLC now owns 190,797 shares of the company's stock worth $3,865,000 after acquiring an additional 860 shares during the last quarter. Finally, R Squared Ltd purchased a new position in Guardian Pharmacy Services during the 4th quarter valued at $30,000.
About Guardian Pharmacy Services
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Articles
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
